October 24, 2020

The Niche

Knoepfler lab stem cell blog

Month: September 2015

2 min read

We’ve been hearing a lot this week about an important new clinical study for vision loss (macular degeneration) in the UK. This team is using retinal pigmented epithelial cells (RPEs) made from embryonic stem cells (ESC). They are now testing safety. The new work in the UK is Moorfields Eye Hospital is a great addition to the growing list of vision stem cell clinical studies and provides real hope for those dealing with macular degeneration. In their PR on the study, part of the …Read More

1 min read

Congratulations to Lorenz Studer as a MacArthur Fellow. The annual selection of MacArthur Fellows highlights creative leaders in a variety of fields. The fellows receive $625,000 with no strings attached. Stem cell biologists have been selected on a regular basis over the years as MacArthur Fellows including Kevin Eggan (2006), Sally Temple (2008), and Yukiko Yamashita (2011). This year’s group of two-dozen 2015 MacArthur Fellows includes stem cell biologist Lorenz Studer (see video above). You can learn much more about Dr. Studer’s work on his …Read More

4 min read

By Jeanne Loring Last Tuesday I visited the FDA headquarters in Maryland, for a meeting called Public Meeting on Patient-Focused Drug Development for Huntington’s and Parkinson’s Diseases. The FDA holds about 6 meetings on different diseases each year, inviting patients and advocates to speak while a panel of FDA directors listens. The FDA representatives at this meeting included Billy Dunn and Eric Bastings, (Director, and Deputy Director, respectively, Division of Neurology Products [DNP], Office of New Drugs), Susanne Goldstein (Medical officer, DNP), and Theresa …Read More

1 min read

With nearly 200 votes in, our poll on whether sex should be considered a form of genetic modification reflects a big divide. The two most polar answers of “definitely yes” and “definitely not” are almost equal, but “yes” is a bit ahead. In the “probably” category of responses, the “yes” answers lead over “not” by a 2:1 margin. Thus, while overall there isn’t a clear consensus, the respondents definitely leaned toward “yes”. It is striking that only about 6% of respondents were undecided as …Read More